Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
about
Spanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decadeBiobanking: The Melding of Research with Clinical CareA Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.Genomic Characterization and Comparison of Multi-Regional and Pooled Tumor Biopsy Specimens.Biopsies: next-generation biospecimens for tailoring therapy.Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network.Molecular alterations in prostate cancer and association with MRI features.Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.Next-gen tissue: preservation of molecular and morphological fidelity in prostate tissue.Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.
P2860
Q26770333-8D7483B3-E405-45BA-B063-4FB90AF7D9B2Q28662280-24B333D6-A2C0-4595-BA00-6406A2B086CDQ33457518-689DE55F-BEFA-4CD3-AE22-990DB62B1F95Q35551492-A56DCA90-3C9A-45D9-B54F-257CA0AD5FD6Q35968893-AAE053A2-ADCC-4B55-9FED-6F712207B030Q38116896-55E66B68-FBA7-4943-9F10-7D016850FEA3Q38404130-1624D69B-0F3B-4C3A-9CC2-D1D1492079BBQ38648768-6AEFC2CA-1729-4911-AA49-F5C27013109CQ38768101-7DCD988E-85E2-4D5E-9AF9-562BCE73895BQ40903462-4C6C4FB5-13D3-454F-9ABD-9E5224910D92Q42792567-3B5B9FD7-0631-4F87-B780-ADD8F8ADF13CQ42932711-B74D7765-E25D-4A44-AA44-77374ECCF14C
P2860
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@ast
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@en
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@nl
type
label
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@ast
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@en
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@nl
prefLabel
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@ast
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@en
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@nl
P2093
P2860
P50
P1476
Next-generation prostate cance ...... onal Cancer Genome Consortium.
@en
P2093
Ashutosh K Tewari
Cyril Abraham
David S Rickman
Kyung Park
Maria M Shevchuk
Naoki Kitabayashi
Philip J Dorsey
Raquel Esgueva
Robert A Leung
Robert Kim
P2860
P356
10.1097/PDM.0B013E31823B6DA6
P577
2012-06-01T00:00:00Z